Alibaba Health Information Technology (HKG:0241) recorded a rise in attributable profit for the year ended March 31 to 1.43 billion yuan from 883.5 million yuan a year prior, a Monday filing with the Hong Kong bourse said.
Earnings per share stood at 0.0888 yuan for the year, down from 0.0627 yuan in the corresponding period of the last fiscal year.
Revenue for the internet solutions provider for the medical and pharmaceutical sector rose by 13% to 30.6 billion yuan in the period from 27 billion yuan a year prior.
The higher revenue was mainly due to the steady development of the pharmaceutical direct sales and ecommerce platform businesses.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。